We report the case of a 27-year-old woman with signs of heparin-induced thrombocytopenia and thrombosis (HITT) and left heart failure presenting for urgent implantation of a left ventricular assist device (LVAD). HITT can occur in 4.2-6.1% of patients with LVADs. If the patient remains hemodynamically stable, implantation can be delayed for several months until the heparin/PF-4 antibodies decline allowing the use of heparin on cardiopulmonary bypass, However, in most cases related to cardiogenic shock, surgery cannot be delayed. We present the case of a patient who underwent implantation of a HeartMate II LVAD and discuss management strategy using bivalirudin during cardiopulmonary bypass.
CITATION STYLE
Garland, C., & Somogyi, D. (2014). Successful implantation of a left ventricular assist device in a patient with heparin-induced thrombocytopenia and thrombosis. Journal of Extra-Corporeal Technology, 46(2), 162–165. https://doi.org/10.1051/ject/201446162
Mendeley helps you to discover research relevant for your work.